The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 02, 2008
Filed:
May. 28, 2004
Hong Lim, Seoul, KR;
Dong Ha Lee, Taejon-si, KR;
Sun OK Kim, Taejon-si, KR;
Sung-eun Yoo, Kongju-si, KR;
Kyu Yang Yi, Taejon-si, KR;
Sun Kyung Lee, Taejon-si, KR;
Jee Hee Suh, Taejon-si, KR;
Nak Jeong Kim, Taejon-si, KR;
Sun Kyung Hwang, Taejon-si, KR;
Tae MI Kim, Taejon-si, KR;
Byung Ho Lee, Taejon-si, KR;
Ho-won Seo, Taejon-si, KR;
Hong Lim, Seoul, KR;
Dong Ha Lee, Taejon-si, KR;
Sun Ok Kim, Taejon-si, KR;
Sung-Eun Yoo, Kongju-si, KR;
Kyu Yang Yi, Taejon-si, KR;
Sun Kyung Lee, Taejon-si, KR;
Jee Hee Suh, Taejon-si, KR;
Nak Jeong Kim, Taejon-si, KR;
Sun Kyung Hwang, Taejon-si, KR;
Tae Mi Kim, Taejon-si, KR;
Byung Ho Lee, Taejon-si, KR;
Ho-Won Seo, Taejon-si, KR;
Schaeffler KG, , DE;
Abstract
The present invention relates to benzopyran derivatives substituted with a thioxobenzoxazole derivative, or pharmaceutically acceptable salts thereof, processes for preparing the same and a pharmaceutical composition containing the above as an effective ingredient Benzopyran derivatives substituted with thioxobenzoxazole derivatives, represented in <Formula 1>, have the function of protecting heart from ischemia-reperfusion both in vivo and in vitro, so that a pharmaceutical composition containing benzopyran derivatives substituted with thioxobenzoxoazole derivatives or pharmaceutically acceptable salts thereof of the present invention as an effective ingredient can be effectively used for the protection of tissues influenced by ischemia-reperfusion, for example, for the protection of heart, nervous cells, brain, retinal cells, storage organs, etc, and for the treatment of diseases caused by ischemia-reperfusion.